PTC Therapeutics | PTCT - Debt



PTC Therapeutics reported $286.01M in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
Acadia Pharmaceuticals USD 56.29M 56.29M Jun/2025
Alnylam Pharmaceuticals USD 1.3B 271.5M Jun/2025
Amgen USD 56.2B 1.18B Jun/2025
Biogen USD 6.59B 296.8M Jun/2025
BioMarin Pharmaceutical USD 603.87M 8.22M Jun/2025
Cytokinetics USD 658.13M 1.01M Mar/2025
Daiichi Sankyo JPY 101.33B 97M Mar/2025
Gilead Sciences USD 24.95B 6M Jun/2025
Incyte USD 42.41M 5.29M Jun/2025
Ionis Pharmaceuticals USD 1.42B 169.27M Jun/2025
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
Novartis USD 31.27B 12M Mar/2025
Pfizer USD 60.93B 1.18B Jun/2025
PTC Therapeutics USD 286.01M 2.12B Jun/2025
Roche Holding CHF 34.44B 5.23B Jun/2024
Sarepta Therapeutics USD 1.35B 215.59M Jun/2025
TG Therapeutics USD 8.98M 235.45M Mar/2025
Ultragenyx Pharmaceutical USD 36.3M 1.98M Jun/2025
Vertex Pharmaceuticals USD 1.53B 121.7M Jun/2025
Xencor USD 67.93M 86.45M Jun/2025